These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 32197436)
1. Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as Biomarkers. Gherman A; Balacescu L; Gheorghe-Cetean S; Vlad C; Balacescu O; Irimie A; Lisencu C Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197436 [TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review. Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194 [TBL] [Abstract][Full Text] [Related]
3. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702 [TBL] [Abstract][Full Text] [Related]
4. Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer. Alves Dos Santos K; Clemente Dos Santos IC; Santos Silva C; Gomes Ribeiro H; de Farias Domingos I; Nogueira Silbiger V Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396209 [TBL] [Abstract][Full Text] [Related]
5. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225 [TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives. Movahedpour A; Ahmadi N; Ghasemi Y; Savardashtaki A; Shabaninejad Z J Cell Biochem; 2019 Oct; 120(10):16316-16329. PubMed ID: 31257636 [TBL] [Abstract][Full Text] [Related]
7. Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer. Canale M; Marisi G; Passardi A; Scarpi E; Ulivi P J Vis Exp; 2019 Mar; (145):. PubMed ID: 30933052 [TBL] [Abstract][Full Text] [Related]
8. Circulating biomarkers for early detection and clinical management of colorectal cancer. Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression. Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150 [TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside. To KK; Tong CW; Wu M; Cho WC World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463 [TBL] [Abstract][Full Text] [Related]
11. Circulating MicroRNAs as Potential Biomarkers for Lung Cancer. Müller S; Janke F; Dietz S; Sültmann H Recent Results Cancer Res; 2020; 215():299-318. PubMed ID: 31605236 [TBL] [Abstract][Full Text] [Related]
12. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. Herreros-Villanueva M; Duran-Sanchon S; Martín AC; Pérez-Palacios R; Vila-Navarro E; Marcuello M; Diaz-Centeno M; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; José Lozano J; García-Cougil M; Martínez-Arranz I; Castells A; Gironella M; Arroyo R Clin Transl Gastroenterol; 2019 Jan; 10(1):e00003. PubMed ID: 30702491 [TBL] [Abstract][Full Text] [Related]
13. Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer. Yörüker EE; Holdenrieder S; Gezer U Clin Chim Acta; 2016 Apr; 455():26-32. PubMed ID: 26797671 [TBL] [Abstract][Full Text] [Related]
14. Detection of circulating microRNAs with Ago2 complexes to monitor the tumor dynamics of colorectal cancer patients during chemotherapy. Fuji T; Umeda Y; Nyuya A; Taniguchi F; Kawai T; Yasui K; Toshima T; Yoshida K; Fujiwara T; Goel A; Nagasaka T Int J Cancer; 2019 May; 144(9):2169-2180. PubMed ID: 30381824 [TBL] [Abstract][Full Text] [Related]
15. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer. Ferracin M; Lupini L; Mangolini A; Negrini M Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900 [TBL] [Abstract][Full Text] [Related]
16. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223 [TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives. Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013 [TBL] [Abstract][Full Text] [Related]
18. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients. Perakis SO; Thomas JE; Pichler M Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901 [TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer. Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878 [TBL] [Abstract][Full Text] [Related]
20. Examining plasma microRNA markers for colorectal cancer at different stages. Sun Y; Liu Y; Cogdell D; Calin GA; Sun B; Kopetz S; Hamilton SR; Zhang W Oncotarget; 2016 Mar; 7(10):11434-49. PubMed ID: 26863633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]